Loading the security overview…
Where the tokens are
Standardised from the company’s filings, newest period first, labelled with the company’s own fiscal calendar. A line the company does not report is left off rather than shown as zero; margins and free cash flow are worked out here, and only where every input is present.
| Line item | Q2 FY262026-06-30 | Q1 FY262026-03-31 | Q4 FY252025-12-31 | Q3 FY252025-09-30 | Q2 FY252025-06-30 | Q1 FY252025-03-31 | Q4 FY242024-12-31 | Q3 FY242024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $4.88B | $4.59B | $2.76B | $2.93B | $2.86B | $3.00B | $2.35B | $2.37B |
| Cost of revenue | $3.79B | $3.23B | $2.62B | $2.59B | $2.55B | $2.26B | $2.07B | $2.00B |
| Gross profit | $1.09B | $1.36B | $135.55M | $346.44M | $310.97M | $740.50M | $284.90M | $369.18M |
| Gross margin | 22.2% | 29.6% | 4.9% | 11.8% | 10.9% | 24.7% | 12.1% | 15.6% |
| Selling, general and administrative | $697.14M | $713.25M | $518.91M | $528.90M | $541.46M | $489.49M | $475.05M | $467.88M |
| Operating expenses | $697.14M | $713.25M | $518.91M | $528.90M | $541.46M | $489.49M | $475.05M | $467.88M |
| Operating income | $388.64M | $643.47M | −$383.36M | −$182.47M | −$230.48M | $251.01M | −$190.15M | −$98.70M |
| Operating margin | 8.0% | 14.0% | -13.9% | -6.2% | -8.0% | 8.4% | -8.1% | -4.2% |
| EBITDA | $394.67M | $650.49M | −$375.48M | −$175.15M | −$223.51M | $257.74M | −$180.92M | −$91.20M |
| Interest income | $0 | $60.61M | $49.61M | $53.22M | $0 | $46.11M | $42.42M | $50.33M |
| Interest expense | −$4.71M | −$5.38M | $1.10M | −$6.86M | −$5.85M | −$5.99M | −$6.03M | −$5.82M |
| Income before taxes | $383.01M | $698.77M | −$352.68M | −$139.29M | −$233.54M | $288.21M | −$153.69M | −$52.31M |
| Income taxes | $21.18M | $19.75M | −$247.00K | −$1.81M | −$5.05M | $12.71M | −$404.00K | $2.08M |
| Net income | $361.83M | $679.02M | −$352.43M | −$137.48M | −$228.49M | $275.51M | −$153.29M | −$54.39M |
| Net margin | 7.4% | 14.8% | -12.8% | -4.7% | -8.0% | 9.2% | -6.5% | -2.3% |
| EPS, basic | $1.20 | $2.28 | −$1.24 | −$0.53 | −$0.89 | $1.10 | −$0.62 | −$0.22 |
| EPS, diluted | $1.10 | $2.07 | −$1.54 | −$0.53 | −$0.89 | $0.92 | −$0.69 | −$0.22 |
| Diluted shares | 333.43M | 329.75M | 228.81M | 259.27M | 255.53M | 305.94M | 222.55M | 243.11M |
Figures describe Oscar Health shares, not any token. As of Aug 7, 2026, from Massive's standardised financials. The company reports these figures; a token's issuer holds the shares and reports nothing of its own here.